Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a promising player in the biotechnology sector, has caught the eye of investors with its significant growth potential and innovative..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) presents an intriguing opportunity for investors with its potential upside of 43.13%, as highlighted by recent analyst evaluations. Operating within the..
For investors keeping a close watch on the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents an intriguing case with a potential upside of 94.47%, according..
Humacyte, Inc. (NASDAQ: HUMA) is capturing the attention of investors with its promising potential in the biotechnology industry and a striking potential upside of 292.86%. Specializing..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is catching the eye of investors with its impressive potential upside of 130.59%, according to analyst ratings. This biotech firm, headquartered..
ATAI Life Sciences N.V. (NASDAQ: ATAI), a trailblazer in the biotechnology sector, offers an intriguing opportunity for investors with a strong focus on mental health treatments...
Sage Therapeutics, Inc. (NASDAQ: SAGE) offers a compelling opportunity for investors within the biotechnology sector, particularly those interested in the development and commercialization of brain health..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a promising player in the biotechnology sector, is capturing investor attention with its ambitious gene therapy programs targeting rare and life-threatening..
OrthoPediatrics Corp. (NASDAQ: KIDS), a key player in the healthcare sector, is making strides in the specialized field of pediatric orthopedic medical devices. As a company..
CeriBell, Inc. (CBLL), a burgeoning player in the healthcare sector, is capturing investor attention with its innovative approach to neurological diagnostics. Based in Sunnyvale, California, this..
Investors with a keen interest in the biotechnology sector will find Replimune Group, Inc. (NASDAQ: REPL) a compelling opportunity. This clinical-stage biotech company is at the..
AMN Healthcare Services Inc (NYSE: AMN) has positioned itself as a key player in the healthcare staffing and solutions industry, specializing in providing technology-driven workforce solutions..
Pharming Group N.V. (PHAR), a Netherlands-based biopharmaceutical firm, is capturing investor attention with its promising growth trajectory and strategic collaborations aimed at addressing rare diseases. With..
Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a burgeoning player in the biotechnology sector, stands out with a significant potential upside of 153.38%, according to the latest analyst..
Inventiva S.A. (NASDAQ: IVA), a clinical-stage biopharmaceutical company based in France, is capturing investor attention with its promising drug development pipeline and significant potential upside. Specializing..
Anavex Life Sciences Corp. (NASDAQ: AVXL), a clinical-stage biopharmaceutical company based in New York, has captured the attention of investors with its promising drug pipeline targeting..
Altimmune, Inc. (NASDAQ: ALT) is a clinical-stage biopharmaceutical company that has caught the eye of investors with its ambitious pipeline and notable potential upside. With a..
Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company, has captured the attention of investors with an eye-catching potential upside of 214.32%. Specializing in precision medicines..
Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector, operates within the medical care facilities industry, focusing on providing senior housing and related..